Bioengineering

The Stanford psychiatrist, neuroscientist and engineer is honored for developing a technology that lets researchers pinpoint the functions — and malfunctions — of specific brain circuits.

A computer simulation that relates muscle activation patterns to harmful pressure on the knee helps participants adopt knee-protective strategies as they walk.

A Stanford scientist and his colleagues show that patients fitted with a chip in their eye are able to integrate what the chip “sees” with objects their natural peripheral vision detects.

A training program for health technology innovators, the center has generated medical technologies that have helped millions of patients and inspired similar training programs worldwide.

Discoveries by Deisseroth and his two co-recipients regarding microbial light-activated molecules led to his development of a way to manipulate selected neurons in living animals to observe changes in their behavior.

CAR-T cell therapy works for many types of blood cancers, but more than half of patients relapse. A Stanford study provides a clue as to why.

Drew Endy, Michael Moseley and Fan Yang have been elected to the American Institute for Medical and Biological Engineering’s college of fellows, which is composed of distinguished medical and biological engineers.

Annelise Barron, Peter Kim, Siddhartha Jaiswal and Keren Haroush will receive grants totaling $10 million to fund their investigations. The awards support risky efforts that could potentially have a big impact in the biomedical sciences.

The Chan Zuckerberg Initiative has awarded $1.49 million to research projects involving Stanford Medicine scientists who will investigate emerging ideas about the role of inflammation in disease.

Karl Deisseroth was awarded the prize for developing optogenetics, which enables remote manipulation of nerve cells using light, and hydrogel-tissue chemistry, which lets light and molecular probes travel through biological tissue…

An effort to design and build simplified ventilators for patients with severe cases of COVID-19 is being led by researchers at Stanford.